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[571 ABSTRACT 
An improved method is provided for determining bac- 
terial levels, especially in samples of aqueous physio- 
logical fluids, which method depends on the quantita- 
tive determination of bacterial adenosine triphosphate 
(ATP) in the presence of non-bacterial ATP. The bac- 
terial ATP is released by cell rupture and is measured 
by an enzymatic bioluminescent assay. A concentra- 
tion technique is included to make the method more 
sensitive. It is particularly useful where the fluid to be 
measured contains an unknown or low bacteria count. 
19 Claims, No Drawings 
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METHOD OF DETECTING AND COUNTING 
BACTERIA 
ORIGIN OF THE INVENTION 
The invention described herein was made by employ- 
ees of the United States Government and may be man- 
ufactured and used by or for the Government for gov- 
ernmental purposes without the payment of any royal- 
ties thereon or therefor. 
This is a continuation-in-part of a prior copending 
application, Ser. No. 475,337, filed May 31, 1974 and 
now abandoned. 
FIELD OF THE INVENTION 
This invention relates to a method for detecting and 
counting the bacteria present, especially in aqueous 
physiological fluids. More particularly, this invention 
relates to an improved method for counting bacteria 
which depends on the presence and determination of 
adenosine triphosphate (ATP), which is nucleotide 
present in all known living matter. 
BACKGROUND OF THE INVENTION 
Procedures for rapid and routine quantitative detec- 
tion and counting of bacteria are important, for in- 
stance, in the practice of medicine, where bacteria 
counts are required for such physiological fluids as 
blood and urine. The prior art includes‘ classical tech- 
niques for growing bacteria, but these are slow and 
require complex media. For instance, methods pres- 
ently used for determining and counting bacteria in 
urine are culture methods which include the streak and 
pour plat methods and the direct methods which in- 
clude microscopic counting and an additional method 
which depends upon the ability of organisms to oxidize 
nitrites to nitrates. These methods have their disadvan- 
tages. Those methods depending on a culture can be 
questioned because the growth of a particular bacteria 
will vary significantly with the particular nutrient and 
other environmental factors. Moreover, a significant 
amount of time is required for growth to occur. The 
direct counting methods have the disadvantage of re- 
quiring highly skilled personnel. 
The prior art now includes the method disclosed in 
U.S. Pat. No. 3,745,090, incorporated herein by refer- 
ence, entitled “Method of mtecting and Counting 
Bacteria in Body Fluids”. The method disclosed is both 
rapid and routine in nature. The method depends on 
the fact that there is some ATP within all known living 
matter, including bacteria. In order to determine the 
bacteria count in a given urine sample, for example, a 
nonionic detergent is added to the urine sample to 
rupture all of the non-bacteria cells, placing the ATP 
from such cells in soluble free form. The non-bacterial 
ATP can then be destroyed by adding an enzyme 
(ATPase), such as apyrase, that will hydrolyze free 
ATP. The apyrase is destroyed and the bacterial cells 
are ruptured at the same time, freeing their ATP, by 
adding a strong inorganic acid such as nitric acid. The 
resultant suspension contains free bacterial ATP and 
the acid. The acid is then neutralized with a buffer or 
diluted with distilled water. For the purpose of the 
remaining test, therefore, the only effective element in 
the suspension is the bacterial ATP. 
A luciferase-luciferin mixture is prepared in soluble 
form with a buffering agent to compensate for the acid 
in the bacterial ATP suspension if the buffer had not 
2 
been previously added to the suspension, so that the 
effectiveness of the luciferase is not overcome. A small 
quantity of magnesium chloride is added. The lucifer- 
ase is an enzyme which catalyzes the reaction of lucif- 
5 erin with ATP in the presence of M g t t ,  which light 
emission being one of the reaction end products. Lucif- 
erin is ia light emitting long chain thiol derivation. 
One part of the bacterial ATP-acid solution is then 
mixed with one part of the luciferase-luciferin mixture. 
10 Bioluminescence will occur as a result of the reaction 
of the ATP with the luciferase, luciferin and the diva- 
lent metal ions. The resulting mixture is then brought 
into the presence of a photomultiplier system where the 
maximum light intensity of the bioluminescence is mea- 
15 sured. The maximum intensity of the bioluminescence 
is related to the amount of ATP present which is, in 
turn, related to the amount of bacteria present in the 
original sample. A detailed description of the light 
measuring apparatus and techniques can be found in 
20 U.S. Pat. No. 3,756,920, issuing from a copending 
continuation-in-part application of U.S. Pat. No. 
3,745,090 entitled “Automatic Instrument for Chemi- 
cal Processing to Detect Micro-organisms in Biological 
Samples by Measuring Light Reactions”, the disclosure 
If the luciferase-luciferin mixture is present in excess 
the intensity of light produced is approximately propor- 
tional to the quantity of ATP present for the normal 
range to ATP concentrations. 
OBJECTS OF THE INVENTION 
Accordingly, it is an object of the present invention 
to provide an improved, more sensitive method for 
detecting and counting bacteria which substantially 
35 prevents or alleviates one or more of the disadvantages 
of the prior art. 
Another object is to provide an improved, more sen- 
sitive method for detecting and counting bacteria utiliz- 
ing a bioluminescent reaction of bacterial ATP when 
40 the sample to be analyzed also contains non-bacterial 
sources of ATP. 
A further object is to provide an improved, more 
sensitive method for detecting and counting bacteria 
which yields more accurate results than methods of the 
Another object is to provide an improved more sensi- 
tive method for detecting and counting bacteria in 
physiological fluid samples utilizing the high specificity 
of an enyzmatic reaction, which method is also capable 
50 of adaption to automatic equipment, thereby lessening 
the expenditure of time and obviating the necessity of 
requiring the use of experienced personnel. 
These and other objects of the present invention will 
become apparent with reference to the following sum- 
55 mary of the invention and the description of the pre- 
ferred embodiments thereof. 
25 of which is also incorporated by reference. 
30 
45 prior art when samples contain low bacteria counts. 
SUMMARY OF THE INVENTION 
According to the present invention. an improved, 
60 more sensitive method is provided for detecting and 
counting bacteria, especially in physiological fluids 
such as urine, which method is especially valuable 
where the sample contains a relatively high level of 
material which would interfere with a luciferase en- 
65 zyme reaction. This method includes first rupturing the 
various non-bacterial cells containing ATP, by addition 
of a non-ionic detergent, without affecting the bacterial 
cells which also contain ATP, putting the ATP from 
3,97 1,703 
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such cells in soluble free form. The sample is then 
concentrated by centrifuging whereby the bacteria and 
any other particulate matter are separated from the 
supernatant phase containing almost all of the soluble 
ATP from the non-bacterial cells. An alternate proce- 
dure is to concentrate by centrifuging prior to the first 
step of rupturing the non-bacterial cells. The non-bac- 
terial ATP is next destroyed by the addition of apyrase 
which hydrolyzes the free ATP. The pH level of the 
solution is then lowered by adding a suitable buffer to 
obtain a pH where the ATP from non-bacterial cells 
still left binding on large molecules and particulate 
matter is minimal. The resultant suspension is again 
centrifuged to reconcentrate the bacteria. The remain- 
ing steps in the method are identical to the prior art 
method disclosed in the aformentioned U.S. Pat. No. 
3,745,090. The apyrase is destroyed and the bacterial 
cells are ruptured, freeing their ATP, by the addition of 
a strong inorganic acid such as nitric acid, leaving a 
solution of free bacterial ATP and the acid. The pH of 
the acid suspension is usually adjusted by use of a suit- 
able buffer and the suspension is sometimes diluted, 
preferably with distilled water. A luciferase-luciferin 
mixture is prepared in soluble form with a buffering 
agent to compensate for the acid in the bacterial ATP 
solution if the buffering agent is not added to the sus- 
pension. A small quantity of magnesium chloride is 
added. One part of the bacterial ATP-acid solution is 
then mixed with one part of the luciferase-luciferin 
mixture. The resulting bioluminescence is measured by 
a photomultiplier system. This method is particularly 
useful where the fluid to be measured contains an un- 
known or low bacteria count. 
DESCRIPTION OF THE INVENTION 
Basically, the object of the present method is to use a 
measurement of bacterial ATP as an indication of the 
number of bacteria present and, in order to do so, the 
interfering non-bacterial ATP must first be removed. 
The first step is to rupture the various non-bacterial 
cells containing ATP by the addition of a non-ionic 
detergent which does not affect the bacterial cells 
which also contain ATP. This places the ATP from the 
non-bacterial cells in soluble free form. In urine speci- 
mens the non-bacterial cells include such cells as eryth- 
rocytes, leucocytes, and epithelial cells. The detergent 
of choice for use with these non-bacterial cells present 
is TRITON X- 100 (octyl phenoxy polyethoxyethanol). 
Other possible detergents used are within the class of 
surfactants as well as any other agents which will lyse 
cell membranes but not rupture bacterial cell walls. 
Organic solvents in various concentrations have been 
used. 
It should be clearly understood that much of the 
present disclosure relates to measuring bacteria present 
in urine. Urine has bacterial cells containing bacterial 
ATP, soluble ATP, bound ATP, (Le. bound to particu- 
late and large molecule matter), and non-bacterial 
(mammalian) cells containing non-bacterial ATP. 
Food similarly has the same constituents except that its 
non-bacterial cells would not necessarily be mamma- 
lian. However, a pure bacterial culture would be ex- 
pected to contain bacterial cells containing bacterial 
ATP, soluble ATP and bound ATP but no non-bac- 
terial cells. In such a case there would be no require- 
ment for the addition of a detergent, in this case, TRI- 
TON X- 100, because there are no non-bacterial cells 
required to be ruptured. 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
5 5  
60 
65 
4 
After the non-ionic detergent is added to the urine 
sample, rupturing of the non-bacterial cells is generally 
carried out at ambient temperature and pressure, the 
sample sometimes being allowed to stand for from 1 
minute to 1 hour, preferably from 5 to 20 minutes, the 
optimum being about 10 minutes. The optimum time 
the sample is allowed to stand after the non-ionic deter- 
gent is added is partially dependent upon the tempera- 
ture since the rate of rupture will be increased appre- 
ciably for each degree of increase in temperature. AI- 
lowing the sample to stand for a long period of time or 
at elevated temperatures is to be avoided since, under 
either of those conditions, the non-ionic detergent 
might begin to attack the bacteria, thereby reducing 
the accuracy of the results obtained. An alternative is 
to allow centrifugation, the next step, for a long enough 
time. After vortexing, the sample is then concentrated 
by centrifuging, filtration, the addition of hydrophobic 
gels or lyophyzation, whereby the bacteria and other 
particulate matter such as membrane remnants from 
the aforementioned tissue cells and crystals from the 
urine are separated from the supernatant phase con- 
taining the soluble constituents of the urine. The super- 
natant phase includes almost all the soluble ATP from 
the non-bacterial cells but not the particulate bound 
non-bacterial ATP. An alternate method would be to 
concentrate by centrifuging prior to the first step of 
rupturing the non-bacterial cells. Nevertheless, the 
better practice is believed to be centrifugation after the 
cell rupturing because this process requires less apy- 
rase. Centrifuging is advantageous because it concen- 
trates the bacteria thereby improving sensitivity and 
also because, it allows removal of almost all the inhibi- 
tors present in the original sample. Typically, a 10 ml 
sample is used for the assay of ATP. 
The non-bacterial ATP is next destroyed by the addi- 
tion of apyrase which hydrolyzes the free soluble ATP 
still present in the pellet. The apyrase is 100% effective 
on free non-bound ATP. The apyrase required must be 
sufficient to destroy one p mole of ATP in approxi- 
mately 15 minutes. 
A small amount of a saline solution is added to the 
apyrase-pellet solution in the centrifuge tube in order 
that any material that might be adhering to the walls of 
the tube will be washed down. Normally, about 5 ml is 
used. If more than that was added more of the apyrase 
solution would have to be added. 
The next problem is to destroy the particulate bound 
ATP in the pellet. In order to accomplish this, the pH 
level of the solution is lowered by adding a suitable 
buffer to lower the pH to a point where ATP left bind- 
ing on large molecules and particulate matter is mini- 
mal. In practice the lowest pH compatible with ade- 
quate apyrase activity is 4.25. A representative buffer 
for this application is sodium malate (Na malate). 
Other suitable buffers would be those with a pK cover- 
ing a range of pH 4 to pH 5 such as glycine, glycyl 
glycine and lactic acid. The necessary concentration 
would be one which will maintain the pH betwen 4 and 
4.5 in the presence of the chemical agents present in 
the sample. The concentration must also be such that it 
will not raise the pH of the subsequent bacterial ex- 
tracting acid above pH 2. As the particulate bound 
ATP is released by the Na malate, the apyrase present 
will destroy it. The resultant suspension is again centri- 
fuged to reconcentrate the bacteria. 
The apyrase must then be destroyed and the bacterial 
cells ruptured to free their ATP. This is done by the 
3,97 1,703 
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addition of a strong inorganic acid such as nitric acid 
leaving a solution of free bacterial ATP and the acid. 
Other suitable acids would include perchloric acid, 
trichloroacetic acid and sulphuric acid or any inorganic 
acid that is highly ionized. The necessary concentra- 
tions are depehdent on the type of the acid and the type 
of bacteria cells to be ruptured. For nitric acid a final 
concentration of between 0.1 and 0.15 N is adequate 
for all bacteria types that have been tested which in- 
clude those bacterial species found in urine. The sus- 
pension will now contain the extracting acid, free bac- 
terial ATP, bacterial ghosts and ghosts from the non- 
bacterial cells. The ghosts from the bacterial and non- 
bacterial cells have been found to be non-interfering 
with respect to the desired reaction. 
At this point in the process three possible alternatives 
exist. A minimal quantity of sterile, deionized water 
may be added to the suspension to reduce the acidity so 
that a minimal quantity of buffer will be required to 
neutralize the acidity of the suspension to the pH opti- 
mal for the luciferase reaction. However, a volume of 
water which will raise the pH above the point where the 
apyrase is inactive is to be avoided. Another alternative 
embodiment may be used when the apyrase is perma- 
nently inactivated by the nitric acid ( HN03) treatment. 
This situation usually occurs when the quantity of re- 
sidual apyrase is small such as when a concentration 
technique is used whereby the bulk of the apyrase is 
discarded prior to the addition of HNO,. As the buffer- 
ing capacity of the tris-hydroxymethyl-aminomethane 
(TRIS) in which the luciferase is dissolved does not 
6 
stabilization, this solution is lyophylized. The lucife- 
rase-luciferin is available commercially in this form. It 
is readied for use by adding water. The quantity of 
water added will depend on the activity desired. It 
should, because of its present high cost, be dissolved to 
a great extent when intended for application not requir- 
ing great sensitivity. An example of an average high 
volume would be dissolve 100 mg in 5 ml of water. A 
,o typical low volume for high sensitivity would call for 
about 75 mg in 1.5 ml of water. 
At this point, a measured quantity, for example, 0. I 
ml of the luciferase-luciferin solution is placed in a 
small transparent container. This container is placed in 
15 a light-tight reaction chamber adjacent to a photomul- 
tiplier tube without yet being light coupled to the tube. 
The container is rotated until it faces the cathode sur- 
face of the tube. 
Now, the ATP is ready to be mixed with the solution 
20 in the container. Typically, a syringe is used to take up 
a 0.1 ml sample of the ATP solution. The syringe is 
then used to pierce a soft rubber septum on top of the 
container now facing the cathode surface of the photo- 
multiplier tube. The syringe contents are then injected 
25 into the container. In this example a 1 to 1 volume 
relationship exists between the ATP solution and the 
luciferase-luciferin solution, but in fact, a 1 to 100 
relationship, in either direction, could be used. 
Upon injection, within 0.5 second, maximum inten- 
sity is achieved, the maximum being generally directly 30 . 
proportional to the amount of ATP present. However, have to be great because of the pre-neutralization of at relative high ATP concentrations, the relationship the HNO3 the luciferase may be dissolved in a h e r  between and maximum light intensity is no longer TRIS concentration at a pH of 7.75. A third alternative 
linear and tends to level off. This is because of two is that if no water is added, the acidity of the resulting 35 
suspension be neutralized by a buffer added to the factors, insufficient luciferase-luciferin and saturation 
suspension prior to mixing with luciferase, or, as an of the photomultiplier tube or amplifier. 
alternative, the luciferase must be prepared with If we now take Our peak light reading and have 
enough buffer to for the acidity of the avoided saturation the quantity of ATP present can be 
suspension. The buffer commonly used, again, is TRIS. 40 determined from the light reading. Again, the light 
It is most often mixed with the luciferase-luciferin mix- output will be directly Proportional to the amount of 
ture. Other suitable buffers include phosphate and ATP present. The photomultiplier output is calibrated 
arsenate buffers or others with a pK of approximately with a standard unit of ATP. The output of the sample 
7. The desired effect is to maintain an optimal pH for being measured is then compared with the light output 
luciferase activity (7.75) when the suspension is finally 45 of the standard unit. For example, 0.0001 mg of ATP 
mixed with the luciferase-luciferin mixture. The would give you a reading of 5000 arbitrary light units. 
amount of buffer added is dependent on the acid con- If the sample gave 2500 arbitrary light units we would 
centration of the sample. At this point in the process, dculate that the sample contain& . 0 5  mg of ATP. 
after the buffer is added, the only effective element in The object is now to determine the amount of hac- 
the suspension is the bacterial ATP. 50 teria present in a given sample. It should be recognized 
The luciferase-luciferin mixture used is prepared in that a different amount of ATP is present in various 
soluble form with a small quantity of magnesium SUI- types of species of bacteria, thus one has to calculate 
phate. the amount of ATP per cell for each species. However, 
ase per m1 is mixed with O.O1 to l.o mg Of luciferin per 55 since variations are relatively small, approximation by 
m1 averaging can be used. On the average it has been 
' '0 mg Of partially purified lucifer- 
with about 1.3 mg per m1 Of magnesium "I- 
determined that there is about 1X10-9, pgm of ATP phate. Actually, any soluble magnesium salt can be used as the objective is to make the solution 0.01 M in per cell. From the example given above where the Mg-. In fact, other divalent metallic ions such as man- sample contained 0.00005 mg of ATP by dividing by ganese can be used but heavy metals should be 
avoided. This solution should be at least 0.05 M in a 60 the figure lx lo-g  Pgm ATP/cell, the result is that the 
where no buffer was added to the acidic suspension. The invention is further illustrated by the following 
Where buffer is added to the acidic suspension the example in which all Parts and Percentages are by 
molarity and p~ should be such SO that when the SUS- weight unless otherwise indicated. This example is illus- 
pension is added to the luciferase-luciferin solution the 65 trative of results obtained with one embodiment of the 
final pH should be 7.75. It should be understood that invention and are provided to teach those skilled in the 
whenever a luciferase-luciferin solution is referred to, it art how to practice the invention and to represent one 
includes a soluble magnesium salt. For purposes of mode contemplated for carrying out the invention. 
buffer with a pK of approximately 7 at a pH of 7.75 5x107 per ml. 
3,971,703 
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EXAMPLE 
Introduction 
The example involves a procedure for obtaining the 
amount of bacteria present in a urine sample. The first 
part of this procedure involves rupturing the non-bac- 
terial cells with a non-ionic detergent to free their ATP 
and then destroying that ATP as well as any free solua- 
ble ATP originally present. 
a. A 10 ml urine sample was mixed with 0.2 ml of a 
6% by volume Triton X- 100 solution. 
b. The sample was vortexed well. 
c. The sample as then centrifuged at ambient pres- 
sure for 15 minutes at 20°C at 10,400 RCF X G and 
then decanted, thereafter, inverted on filter paper for a 
period of 5 minutes; a pellet remains. 
d. 1.0 ml of a solution of 10 mg apyrase/ml 0.03 M 
CaCI, was added to the pellet. 
e. The sample was then vortexed well. 
f. The sample was then mixed well with 5.0 ml of a 
0.9% saline solution and the sample allowed to stand 
for 15 minutes. 
g. The sample was then mixed with 1.0 ml of a solu- 
tion of 0.25 M Na malate-0.005 M sodium arsenate 
having a pH of 4.25. 
h. The sample was again centrifuged at  10,400 RCF 
X G for 15 minutes at 20°C and the decant, thereafter, 
inserted on filter paper. 
i. The sample was then mixed with 0.2 ml of 0.1 N 
HNO, and, thereafter, vortexed well and allowed to 
stand for 5 minutes. 
j. The sample was then mixed with 0.2 ml of sterile, 
deionized H,O. 
k. The sample was vortexed well. 
1. A syringe was used to extract 0.1 ml of the sample 
which was then injected through the septum of a con- 
tainer facing the cathode of a photomultiplier tube. 
The container contains 0. I ml of a luciferase-luciferin 
solution which is 0.01 M in MgSO, and 0.2 M Tris, at 
a pH of 8.25. 
m. A reading was then taken from the photometer of 
2X108 light units where a standard ATP sample con- 
taining 1X10-2 pgm/ml was used to zstablish a base 
calibration of the photometer at a reading of 2X107 
light units. 
n. The sample under examination was calculated to 
have an ATP concentration of 1 X lo-' pgm/ml which, 
using the average figure of 1X10-9 pgm/ATP/cell it is 
calculated that the sample had about 1 X I O8 bacterial 
cells per ml. 
The method of the instant invention, as disclosed 
herein, results in an improved, more sensitive method 
for detecting and counting bacteria. It can be con- 
ducted by non-microbiologists, freeing more highly 
skilled personnel for more effective use. The test is 
suitable for all bacteria; it is effective for aerobes and 
anaerobes; and it is generally unaffected by the pres- 
ence of bacteriostatic agents which inhibit growth. 
The method is not only suitable for use in analyzing 
urine samples to determine urinary tract infections by 
measuring the level of bacteria, but is is also adaptable 
to the determination of bacterial levels in other aque- 
ous physiological fluids such as lymph fluid, plasma, 
blood, spinal fluid, saliva, and mucus, to name only a 
few, as well as bacteria removed from such a fluid. 
Further, it is particularly applicable to measuring bac- 
terial levels in aqueous physiological fluids which have, 
8 
in addition to the bacteria, both free soluble ATP and 
non-bacterial cells containing ATP. 
The principles, preferred embodiments, and modes 
of operation of the present invention have been de- 
scribed in the foregoing specification. The invention 
which is intended to be protected herein, however, is 
not be construed as limited to the particular forms 
disclosed since these are to be regarded as illustrative 
rather than restrictive. Variations and changes may be 
l o  made by those skilled in the art without departing from 
the spirit of the present invention. 
What is claimed is: 
1. A method of detecting and counting bacteria in a 
sample which contains bacterial cells and non-bacterial 
adenosine triphosphate comprising treating said sample 
by: 
a. removing soluble and non-bacterial adenosine 
triphosphate; 
b. desorbing bound adenosine triphosphate, the de- 
sorbed adenosine triphosphate also being removed; 
c. rupturing bacterial cells, thereby releasing bacte- 
rial adenosine triphosphate; 
d. adding a portion of the treated sample to a lucife- 
e. measuring the emitted light level. 
2. The method of claim 1 wherein the desorbing of 
bound adenosine triphosphate is carried ou t  through 
lowering the pH of the sample. 
3. The method of claim 2 wherein the pH is lowered 
by adding sodium malate. 
4. The method of claim 3 wherein the sodium malate 
lowers pH to a level of between 4 and 4.5. 
5. The method of claim 1, wherein the sample has its 
35 bacterial cells ruptured using an acid and thereafter has 
the hydrogen ion concentration of the acid treated 
sample lowered. 
6. The method of claim 5 wherein the desorbing of 
bound adenosine triphosphate is carried out through 
7. The method of claim 6 wherein the pH is lowered 
8. The method of claim 7 wherein the sodium malate 
9. A method of detecting and counting bacteria in a 
a. rupturing bacterial cells using an acid, thereby 
releasing bacterial adenosine triphosphate; 
b. lowering the hydrogen ion concentration of the 
acid treated sample by the addition of sterile, de- 
ionized water 
c. adding a portion of the treated sample to a lucife- 
rase-luciferin solution; and 
d. measuring the emitted light level. 
10. The method of claim 9 wherein prior to rupturing 
the bacterial cells bound adenosine triphosphate are 
desorbed and removed. 
11. The method of claim 1 0  wherein the desorbing of 
60 bound adenosine triphosphate is carried out through 
12. The method of claim 11 wherein the pH is low- 
13. The method of claim 1 2  wherein the sodium 
65 malate lowers the pH to a level of between 4 and 4.5. 
14. A method of detecting and counting bacteria in a 
fluid sample which contains bacterial and non-bacterial 
cells containing adenosine triphosphate comprising: 
20 
25 rase-luciferin solution; and 
30 
40 lowering the pH of the sample. 
by adding sodium malate. 
45 lowers the pH to a level of between 4 and 4.5. 
sample comprising treating said sample by: 
55 
lowering the pH of the sample. 
ered by adding sodium malate. 
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a. concentrating the non-soluble material in the fluid 
sample by removing the suspending fluid by filtra- 
tion; 
b. treating said sample by rupturing the non-bacterial 
cells with the addition of octyl phenoxy polyethox- 
yethanol to release adenosine triphosphate present 
in the non-bacterial cells without rupturing the 
bacterial cells; 
c. hydrolyzing non-bacterial adenosine triphosphate 
with the addition of apyrase; 
d. desorbing bound adenosine triphosphate by lower- 
ing the pH to between 4 and 4.5 with the addition 
of sodium malate, the desorbed adenosine triphos- 
phate also being hydrolyzed; apyrase. 
e. removing the hydrolyzing agent and rupturing the 
bacterial cells with the addition of nitric acid, 
thereby releasing adenosine triphosphate; 
f. reducing the hydrogen ion concentration by adding 
sterile, deionized water; 
g. adding a portion of the treated sample to a lucife- 
rase-luciferin solution, and 
h. measuring the emitted light level. 
15. A method of detecting and counting bacteria 
comprising: 25 
a. treating a solution containing bacterial cells and 
non-bacterial ATP by the addition of an ATP-ase; 
b. reducing the amount of the ATP-ase present by a 
concentration technique to a level where the re- 
maining ATP-ase can be kept inactive; 
c. rupturing the bacterial cells; 
d. reducing the acidity of the rupturing agent to a pH 
that will not allow reactivation of the ATP-ase by 
the addition of a diluent; 
e. adding a portion of the treated sample to a lucife- 
rase-luciferin solution containing a bufferin; and 
f. measuring the emitted light level. 
16. The method of claim 15 wherein the ATP-ase is 
17. The method of claim 15 wherein the rupturing 
agent is nitric acid. 
18. The method of claim 15 wherein the acidity of 
the rupturing agent is reduced by the addition of sterile, 
19. The method of claim 15 wherein the ATP-ase is 
apyrase, the rupturing agent is nitric acid and the acid- 
ity of the rupturing agent i s  reduced by the addition of 
sterile deionized water. 
l o  
2o deionized water. 
* * * * *  
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